Running on empty: cardiovascular reserve capacity and late effects of therapy in cancer survivorship.
about
Muscle dysfunction in cancer patientsSafety and efficacy of resistance training in germ cell cancer patients undergoing chemotherapy: a randomized controlled trial.Cardiovascular Late Effects and Exercise Treatment in Breast Cancer: Current Evidence and Future DirectionsSafety and efficacy of aerobic training in patients with cancer who have heart failure: an analysis of the HF-ACTION randomized trialCancer survivorship issues: life after treatment and implications for an aging populationExercise and risk of major cardiovascular events in adult survivors of childhood hodgkin lymphoma: a report from the childhood cancer survivor study.Cardiopulmonary exercise testing prior to myeloablative allo-SCT: a feasibility study.Utility of 3-dimensional echocardiography, global longitudinal strain, and exercise stress echocardiography to detect cardiac dysfunction in breast cancer patients treated with doxorubicin-containing adjuvant therapy.Prognostic Importance of Pretransplant Functional Capacity After Allogeneic Hematopoietic Cell TransplantationVentricular-Arterial Coupling in Breast Cancer Patients After Treatment With Anthracycline-Containing Adjuvant ChemotherapyTreatment-related cardiovascular late effects and exercise training countermeasures in testicular germ cell cancer survivorship.Current and emerging modalities for detection of cardiotoxicity in cardio-oncology.Exercise and Risk of Cardiovascular Events in Women With Nonmetastatic Breast Cancer.Adolescents and young adult cancer survivors: exercise habits, quality of life and physical activity preferences.Cardiovascular Function in Long-Term Hematopoietic Cell Transplantation Survivors.Breast Cancer Survivorship and Cardiovascular Disease: Emerging Approaches in Cardio-Oncology.Aging in a Relativistic Biological Space-Time.Rationale and design of the Caloric Restriction and Exercise protection from Anthracycline Toxic Effects (CREATE) study: a 3-arm parallel group phase II randomized controlled trial in early breast cancer
P2860
Q26822365-39E5F32F-6C87-4133-9141-1E0F43FB4A75Q33877463-291A92BA-3DF6-4C98-AD78-999049A56E29Q33907581-ED5B0DD4-1E4A-4BFB-853A-9B1DCE76D92EQ34001004-EC578EDE-02C8-42A2-A168-095CB054DC49Q34185068-415B7ADE-690B-4FD4-BCA8-6DC1E8F3A17AQ34451772-E6B61C14-51B2-4BC5-8123-EEB4F8142DFFQ35892403-50877B97-0837-40C8-9856-4BD78507293FQ35905883-DBB65C59-A34C-447D-90F9-98C792F8B7A4Q36478727-F86B1AA4-CAC1-4E23-BD15-EDC9E36341E7Q36558438-92D5057E-C1CD-4163-93D0-6D76D26BC2C0Q37251177-F7DBCF9E-1816-48A2-BF55-30E00A4D8F23Q38559474-2C6BFC09-1280-4E7A-955B-9B2265208D3DQ40739263-E294E67A-5E23-4117-9129-8CE18F4B478FQ45014779-72313F56-F75C-4203-BE0F-F2C0467390ACQ46015912-2BC96827-487A-4528-8F2F-42D50EBEE1DAQ53661913-7DC21762-CD74-4CA9-A9F4-F53D9AFD3D14Q55004429-801D084E-36FB-4C75-A908-2F251B6D1B7BQ58768520-B0725759-B3E7-4EF6-90DC-735C7EE4FA5B
P2860
Running on empty: cardiovascular reserve capacity and late effects of therapy in cancer survivorship.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Running on empty: cardiovascul ...... herapy in cancer survivorship.
@ast
Running on empty: cardiovascul ...... herapy in cancer survivorship.
@en
type
label
Running on empty: cardiovascul ...... herapy in cancer survivorship.
@ast
Running on empty: cardiovascul ...... herapy in cancer survivorship.
@en
prefLabel
Running on empty: cardiovascul ...... herapy in cancer survivorship.
@ast
Running on empty: cardiovascul ...... herapy in cancer survivorship.
@en
P2093
P2860
P356
P1476
Running on empty: cardiovascul ...... herapy in cancer survivorship.
@en
P2093
Graeme J Koelwyn
John R Mackey
Lee W Jones
Michel Khouri
P2860
P304
P356
10.1200/JCO.2012.44.0891
P407
P577
2012-10-08T00:00:00Z